These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9324262)

  • 1. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins.
    Li XZ; Nikaido H; Williams KE
    J Bacteriol; 1997 Oct; 179(19):6127-32. PubMed ID: 9324262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
    Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
    Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
    Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
    Xia P; Feng P; Zhong L; Lu X; Lei B
    Chin Med J (Engl); 2002 Jan; 115(1):31-5. PubMed ID: 11930654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli.
    Mortimer PG; Piddock LJ
    J Antimicrob Chemother; 1993 Aug; 32(2):195-213. PubMed ID: 8226422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cefepime and other beta-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():63-74. PubMed ID: 8150768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli.
    Coldham NG; Webber M; Woodward MJ; Piddock LJ
    J Antimicrob Chemother; 2010 Aug; 65(8):1655-63. PubMed ID: 20513705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of halides on plasmid-mediated silver resistance in Escherichia coli.
    Gupta A; Maynes M; Silver S
    Appl Environ Microbiol; 1998 Dec; 64(12):5042-5. PubMed ID: 9835606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver resistance in Escherichia coli R1.
    Starodub ME; Trevors JT
    J Med Microbiol; 1989 Jun; 29(2):101-10. PubMed ID: 2659795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active efflux of bile salts by Escherichia coli.
    Thanassi DG; Cheng LW; Nikaido H
    J Bacteriol; 1997 Apr; 179(8):2512-8. PubMed ID: 9098046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli mutants resistant to uncouplers of oxidative phosphorylation.
    Ito M; Ohnishi Y
    Microbiol Immunol; 1982; 26(11):1079-84. PubMed ID: 6762486
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential permeability for lipophilic compounds in uncoupler-resistant cells of Escherichia coli.
    Sedgwick EG; Bragg PD
    Biochim Biophys Acta; 1992 Jan; 1099(1):45-50. PubMed ID: 1739727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of ompF and ompC porins in pathogenesis of avian pathogenic Escherichia coli.
    Hejair HMA; Zhu Y; Ma J; Zhang Y; Pan Z; Zhang W; Yao H
    Microb Pathog; 2017 Jun; 107():29-37. PubMed ID: 28315387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli.
    Cohen SP; McMurry LM; Levy SB
    J Bacteriol; 1988 Dec; 170(12):5416-22. PubMed ID: 2848006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of internal loop dynamics in antibiotic permeability of outer membrane porins.
    Vasan AK; Haloi N; Ulrich RJ; Metcalf ME; Wen PC; Metcalf WW; Hergenrother PJ; Shukla D; Tajkhorshid E
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35193963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased resistance to multiple drugs by introduction of the Enterobacter cloacae romA gene into OmpF porin-deficient mutants of Escherichia coli K-12.
    Komatsu T; Ohta M; Kido N; Arakawa Y; Ito H; Kato N
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2155-8. PubMed ID: 1662028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the Fitness Costs of Antibiotic Resistance Due To Reduced Outer Membrane Permeability by Upregulation of Alternative Porins.
    Knopp M; Andersson DI
    Mol Biol Evol; 2015 Dec; 32(12):3252-63. PubMed ID: 26358402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of the Cus system as a major determinant of constitutive Escherichia coli silver resistance of chromosomal origin.
    Lok CN; Ho CM; Chen R; Tam PK; Chiu JF; Che CM
    J Proteome Res; 2008 Jun; 7(6):2351-6. PubMed ID: 18419149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.